Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells

Oncogene
T MochizukiTohru Kamata

Abstract

Pancreatic adenocarcinoma is an aggressive human malignancy and is characterized by resistance to apoptosis. Recently, NADPH oxidase (Nox) 4-mediated generation of intracellular reactive oxygen species (ROS) was proposed to confer antiapoptotic activity and thus a growth advantage to pancreatic cancer cells. The signaling mechanism by which Nox4 transmits cell survival signals remains unclear. Here, we show that both a flavoprotein inhibitor, diphenylene iodonium (DPI), and small interfering RNAs designed to target Nox4 mRNA (siNox4RNAs) inhibited superoxide production in PANC-1 pancreatic cancer cells, and depletion of ROS by DPI or siNox4RNAs induced apoptosis. Parallely, DPI treatment and siNox4RNA transfection blocked activation of the cell survival kinase AKT by attenuating phosphorylation of AKT. Furthermore, AKT phosphorylation of apoptosis signal-regulating kinase 1 (ASK1) on Ser-83 was reduced by DPI and siNox4RNAs. When ASK1Ser83Ala (an AKT phosphorylation-defective ASK1 mutant) was introduced into PANC-1 cells, this mutant alone induced apoptosis. But, addition of DPI or co-transfection of siNox4RNA had no additive effect, indicating that the mutant can substitute for these reagents in apoptosis induction. Taken toge...Continue Reading

References

Jan 25, 1985·Science·P A Cerutti
Apr 1, 1994·Current Opinion in Cell Biology·G M Bokoch
Feb 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·K HiroseK Matsushima
Feb 21, 1997·Cell·T F FrankeL C Cantley
Apr 8, 1998·Current Opinion in Genetics & Development·D R Alessi, P Cohen
May 1, 1999·The Journal of Biological Chemistry·K I LinR R Ratan
May 9, 2000·The Journal of Biological Chemistry·X WangN J Holbrook
Oct 18, 2000·The Journal of Biological Chemistry·A ShioseH Sumimoto
Jan 12, 2001·Molecular and Cellular Biology·A H KimM V Chao
Sep 19, 2001·The Journal of Biological Chemistry·K MiuraT Kamata
Mar 8, 2002·Cellular Signalling·Karleen M Nicholson, Neil G Anderson
Mar 23, 2002·Science·Thijn R BrummelkampReuven Agami
Mar 30, 2002·The Journal of Biological Chemistry·Yoko OgawaraYukiko Gotoh
May 9, 2002·American Journal of Physiology. Cell Physiology·Sukhdev S BrarJohn R Hoidal
Apr 11, 2003·American Journal of Physiology. Cell Physiology·Sukhdev S BrarJohn R Hoidal
Oct 9, 2003·The EMBO Journal·Nick R LeslieC Peter Downes
Mar 25, 2004·Nature Reviews. Immunology·J David Lambeth
May 25, 2004·The Journal of Biological Chemistry·Eva C VaqueroAnna S Gukovskaya
Sep 10, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hye Sun ParkYun Soo Bae
Dec 25, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Talija DjordjevicAgnes Görlach

❮ Previous
Next ❯

Citations

Jun 1, 2012·Cellular and Molecular Life Sciences : CMLS·Sebastian AltenhöferHarald H H W Schmidt
Dec 13, 2006·Cancer Metastasis Reviews·Wen-Sheng Wu
Mar 20, 2012·Current Hematologic Malignancy Reports·N MuvarakF V Rassool
Sep 15, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Can-Liang LuYun-Fei Yuan
Oct 7, 2011·Cell Death & Disease·D R Gough, T G Cotter
Aug 25, 2012·Nature Reviews. Cancer·Karen Block, Yves Gorin
Oct 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Min ZhangAjay M Shah
Oct 19, 2010·The Journal of Biological Chemistry·Ki Soon KimIck Young Kim
Sep 22, 2006·Antioxidants & Redox Signaling·Kathy K Griendling
Sep 12, 2008·Antioxidants & Redox Signaling·Randall S FreyAsrar B Malik
Nov 13, 2008·Antioxidants & Redox Signaling·Marcia A Ogasawara, Hui Zhang
Apr 1, 2009·Antioxidants & Redox Signaling·David J R Fulton
Apr 1, 2009·Antioxidants & Redox Signaling·Brian GriffithVictor J Thannickal
Jun 30, 2009·Antioxidants & Redox Signaling·Gillian GroegerThomas G Cotter
Sep 4, 2010·Antioxidants & Redox Signaling·Domenico Del PrincipeMaria Valeria Catani
Jan 1, 2009·Journal of Innate Immunity·Mark T Quinn, Igor A Schepetkin
Mar 13, 2010·American Journal of Respiratory and Critical Care Medicine·David GozalAviv D Goldbart
Aug 26, 2006·American Journal of Respiratory Cell and Molecular Biology·Yijie WangClay B Marsh
Jun 10, 2014·PloS One·Cristiane Ribeiro-PereiraChristina Barja-Fidalgo
Jan 17, 2012·Journal of Clinical Biochemistry and Nutrition·Masato KatsuyamaChihiro Yabe-Nishimura
Jan 22, 2011·Experimental & Molecular Medicine·Ji Min SeoJae Hong Kim
Sep 21, 2013·Annual Review of Pathology·J David Lambeth, Andrew S Neish
Jun 16, 2012·Molecular Biology International·Marilyn GordonShairaz Baksh
May 8, 2014·Médecine sciences : M/S·Sarah Garrido-UrbaniBeat A Imhof
Oct 26, 2013·Antioxidants & Redox Signaling·Jennifer L MeitzlerJames H Doroshow
Nov 5, 2013·Antioxidants & Redox Signaling·Anna KoniorTomasz J Guzik
Oct 8, 2013·Antioxidants & Redox Signaling·Karen BernardVictor J Thannickal
Mar 19, 2014·Antioxidants & Redox Signaling·Aaron K HolleyDaret K St Clair
May 30, 2008·Seminars in Immunopathology·J David LambethRobert A Clark
May 15, 2012·Cellular and Molecular Life Sciences : CMLS·Michael Y Bonner, Jack L Arbiser
Apr 8, 2010·Free Radical Research·Geou-Yarh Liou, Peter Storz
May 8, 2015·Journal of Drug Targeting·Shuhui Guo, Xiuping Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis